Stock Information
ACADIA Pharmaceuticals Inc (ACAD)
Ticker Symbol: ACAD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,755.84 mil
Piotroski score: 4
PE Ratio: 9.5385
EPS (TTM): 2.2805
Revenue (TTM): $4.80 M
Dividend Yield: N/A%
ROE: 41.9%
Latest News
-
Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026
Wed, Apr 15, 2026 4:06 PM
Key Financials
Financial data not available